Organizational Strategy - Sustainable Development - L'Oréal
Organizational Strategy - Sustainable Development - L'Oréal
Organizational Strategy - Sustainable Development - L'Oréal
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5 L’oréaL - GrI DaTa SHEETS 2011<br />
- Group<br />
2010: €3.0569 billion; 15.7% of turnover<br />
2011: €3.2926 billion; 16.2% of turnover<br />
* Not allocated = group central expenses, basic research, stock options, free shares and miscellaneous. In % of cosmetics turnover.<br />
** group share, i.e. 50%.<br />
as in 2010, this year all divisions again showed an increase in operating profitability, in particular L’oréal Luxe, up by 180 basis points.<br />
The Body Shop improved its profitability in 2011.<br />
Finally, Galderma experienced competition in generic products for two important medicaments, Differin 0.1% and Loceryl.<br />
PROFITabILITY PeR GeOGRaPHICaL ZONe<br />
Operating profit:<br />
Western europe<br />
2010: €1.5220 billion; 21.6% of turnover<br />
2011: €1.5123 billion; 20.9% of turnover<br />
North america<br />
2010: €708.5 million; 16.5% of turnover<br />
2011: €810.1 million; 18.4% of turnover<br />
New Markets<br />
2010: €1.1248 billion; 16.9% of turnover<br />
2011: €1.3281 billion; 18.4% of turnover<br />
Total for cosmetics zones*<br />
2010: €3.3853 billion; 18.7% of turnover<br />
2011: €3.6506 billion; 19.3% of turnover<br />
* Before non-allocated.<br />
The profitability of western Europe has declined slightly to 20.9%, going back to its 2009 level.<br />
The profitability of the North america and New Markets zones has again grown strongly, to reach 18.4% of turnover.<br />
NeT eaRNINGs PeR sHaRe**: €4.32<br />
Consolidated profit and loss account: from operating profit to net profit excluding non-recurring items.<br />
Operating profit<br />
2010: €3.0569 billion<br />
2011: €3.2926 billion<br />
Products and financial charges excluding dividends received<br />
2010: €–35.6 million<br />
2011: €–25.2 million<br />
sanofi dividends<br />
2010: €283.8 million<br />
2011: €295.8 million<br />
Profit before tax, excluding non-recurring items<br />
2010: €3.3052 billion<br />
2011: €3.5631 billion<br />
Tax on profits, excluding non-recurring items<br />
2010: €–931.9 million<br />
2011: €–977.6 million<br />
Minority interests<br />
2010: €–2.3 million<br />
2011: €–2.5 million<br />
Group share of net profit excluding non-recurring items*<br />
2010: €2.3709 billion<br />
2011: €2.5829 billion<br />
4/14